Skip to content

Welcome to Discover Pharma! Today is : November 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical & Regulatory

  • Clinical & Regulatory,Digital & Data,Medical devices,Therapeutic Areas

    FDA approves first at-home non-drug treatment for depression

    US regulators have authorised the first at-home brain-stimulation treatment for [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    AC Immune interim Phase 2 data suggest ACI-7104.056 may slow Parkinson’s disease progression

      AC Immune SA has reported positive interim results from [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    Rapid sepsis test linked to lower mortality and shorter hospital stays in academic centre study

    A rapid sepsis test used in the emergency department at [...]

    May 5, 2026
  • Clinical & Regulatory,Therapeutic Areas

    UCB reports positive phase 3 Gemz results as fenfluramine cuts seizure frequency in CDKL5 deficiency disorder

    UCB has reported positive findings from the Gemz phase 3 [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Today Discover Pharma launches its annual 12 Days of Christmas campaign featuring CluePoints insight on RBQM

    The launch of the 12 Days of Christmas campaign marks [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Vortex launches clinical study using liquid biopsy technology to advance cancer monitoring

      Vortex Liquid Biopsy Solutions has launched a clinical study [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Orano Med and Roche move two-step 212Pb therapy into clinical development

    Orano Med has advanced its long-running collaboration with Roche as [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Saphnelo self-administration recommended for EU approval for systemic lupus

    AstraZeneca has received a positive recommendation from the Committee for [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Medical devices,Therapeutic Areas

    Neuraxpharm and mjn-neuro plan launch of digital solution for early detection of epileptic seizures

    Neuraxpharm and mjn-neuro are preparing to launch a digital health [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain

    eXmoor and UCL partner to accelerate academic cell and gene therapy programmes

    eXmoor Pharma has formed a strategic collaboration with University College [...]

    May 5, 2026
Previous424344Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow
    Categories: Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
  • FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness
    Categories: Advanced Therapies, Clinical & Regulatory, Genomics and sequencing, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top